tryptamine has been researched along with Migraine Disorders in 4 studies
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pathogenesis of migraine, as well as cluster headache (CH), is yet a debated question." | 2.82 | Elusive amines: migraine depends on biochemical abnormalities. ( D'Andrea, G; Gucciardi, A; Leon, A, 2022) |
| "Alniditan is a new migraine-abortive agent." | 1.29 | Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin ( Gommeren, W; Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Schotte, A; Van de Weyer, I; Van Gompel, P; Vanhoenacker, P; Wouters, R, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glen, RC | 1 |
| Martin, GR | 1 |
| Hill, AP | 1 |
| Hyde, RM | 1 |
| Woollard, PM | 1 |
| Salmon, JA | 1 |
| Buckingham, J | 1 |
| Robertson, AD | 1 |
| Leysen, JE | 1 |
| Gommeren, W | 1 |
| Heylen, L | 1 |
| Luyten, WH | 1 |
| Van de Weyer, I | 1 |
| Vanhoenacker, P | 1 |
| Haegeman, G | 1 |
| Schotte, A | 1 |
| Van Gompel, P | 1 |
| Wouters, R | 1 |
| Lesage, AS | 1 |
| D'Andrea, G | 2 |
| Gucciardi, A | 1 |
| Leon, A | 2 |
| D'Amico, D | 1 |
| Bussone, G | 1 |
| Bolner, A | 1 |
| Aguggia, M | 1 |
| Saracco, MG | 1 |
| Galloni, E | 1 |
| De Riva, V | 1 |
| D'Arrigo, A | 1 |
| Colavito, D | 1 |
| Perini, F | 1 |
1 review available for tryptamine and Migraine Disorders
| Article | Year |
|---|---|
Elusive amines: migraine depends on biochemical abnormalities.
Topics: Amines; Cluster Headache; Headache; Humans; Migraine Disorders; Neurotransmitter Agents; Tension-Typ | 2022 |
3 other studies available for tryptamine and Migraine Disorders
| Article | Year |
|---|---|
Computer-aided design and synthesis of 5-substituted tryptamines and their pharmacology at the 5-HT1D receptor: discovery of compounds with potential anti-migraine properties.
Topics: Animals; Aorta; Computer-Aided Design; Drug Design; Haplorhini; In Vitro Techniques; Migraine Disord | 1995 |
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin
Topics: Animals; Benzopyrans; Cattle; Cloning, Molecular; Glioma; HeLa Cells; Humans; Mice; Migraine Disorde | 1996 |
Tryptamine levels are low in plasma of chronic migraine and chronic tension-type headache.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Chronic Disease; Female; Humans; Male; Middle Age | 2014 |